LAG3 and pancreatic neoplasm: We also examined PD-1, Tim-3, and LAG-3 by flow cytometry, finding a significant reduction in surface levels of these T cell exhaustion markers in mifepristone-treated HY24409 pancreatic tumors (Fig. 4n).